{
  "meta": {
    "data_length": 1,
    "message": "Proposition id 532 retrieved successfully",
    "request_url": "http://api.moalmanac.org/propositions?proposition_id=532",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.083142,
    "timestamp_received": "2026-06-08T19:59:17.889150+00:00Z",
    "timestamp_returned": "2026-06-08T19:59:17.972292+00:00Z",
    "trace_id": "5a0f78e3-e980-46d1-a408-93e979fbd8d6"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-05-07"
  },
  "data": [
    {
      "id": 532,
      "type": "VariantTherapeuticResponseProposition",
      "predicate": "predictSensitivityTo",
      "biomarkers": [
        {
          "id": 0,
          "name": "CD30 +",
          "genes": [],
          "type": "CategoricalVariant",
          "extensions": [
            {
              "name": "biomarker_type",
              "value": "Protein expression"
            },
            {
              "name": "present",
              "value": true
            },
            {
              "name": "marker",
              "value": "CD30"
            },
            {
              "name": "unit",
              "value": "status"
            },
            {
              "name": "equality",
              "value": "="
            },
            {
              "name": "value",
              "value": "Positive"
            }
          ]
        }
      ],
      "subjectVariant": {},
      "conditionQualifier": {
        "id": 80,
        "conceptType": "Disease",
        "name": "Hodgkin Lymphoma",
        "primaryCoding": {
          "id": "oncotree:HL",
          "code": "HL",
          "name": "Hodgkin Lymphoma",
          "system": "https://oncotree.mskcc.org",
          "systemVersion": "oncotree_2021_11_02",
          "iris": [
            "https://oncotree.mskcc.org/?version=oncotree_2021_11_02&field=CODE&search=HL"
          ]
        },
        "mappings": []
      },
      "objectTherapeutic": {
        "id": 104,
        "membership_operator": "AND",
        "therapies": [
          {
            "id": 2,
            "conceptType": "Drug",
            "name": "Doxorubicin",
            "primaryCoding": {
              "id": "ncit:C456",
              "code": "C456",
              "name": "Doxorubicin",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C456"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:3639",
                  "code": "3639",
                  "name": "doxorubicin",
                  "system": "RxNorm",
                  "systemVersion": "20250602",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=3639"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:4187583",
                  "code": "4187583",
                  "name": "Doxorubicin",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/4187583"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:372817009",
                  "code": "372817009",
                  "name": "Doxorubicin",
                  "system": "SNOMED",
                  "systemVersion": "2025-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=372817009&edition=MAIN/2026-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:1338512",
                  "code": "1338512",
                  "name": "doxorubicin",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/1338512"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "Topoisomerase inhibition"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Chemotherapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          },
          {
            "id": 3,
            "conceptType": "Drug",
            "name": "Vinblastine",
            "primaryCoding": {
              "id": "ncit:C930",
              "code": "C930",
              "name": "Vinblastine",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C930"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:11198",
                  "code": "11198",
                  "name": "vinblastine",
                  "system": "RxNorm",
                  "systemVersion": "20250602",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=11198"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:4305258",
                  "code": "4305258",
                  "name": "Vinblastine",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/4305258"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:387051009",
                  "code": "387051009",
                  "name": "Vinblastine",
                  "system": "SNOMED",
                  "systemVersion": "2025-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=387051009&edition=MAIN/2026-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:19008264",
                  "code": "19008264",
                  "name": "vinblastine",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/19008264"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "Vinca alkaloid chemotherapy"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Targeted therapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          },
          {
            "id": 1,
            "conceptType": "Drug",
            "name": "Dacarbazine",
            "primaryCoding": {
              "id": "ncit:C411",
              "code": "C411",
              "name": "Dacarbazine",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C411"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:3098",
                  "code": "3098",
                  "name": "dacarbazine",
                  "system": "RxNorm",
                  "systemVersion": "20250602",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=3098"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:4306881",
                  "code": "4306881",
                  "name": "Dacarbazine",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/4306881"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:387441003",
                  "code": "387441003",
                  "name": "Dacarbazine",
                  "system": "SNOMED",
                  "systemVersion": "2025-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=387441003&edition=MAIN/2026-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:1311409",
                  "code": "1311409",
                  "name": "dacarbazine",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/1311409"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "Nonclassical alkylating chemotherapy"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Chemotherapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          },
          {
            "id": 0,
            "conceptType": "Drug",
            "name": "Brentuximab vedotin",
            "primaryCoding": {
              "id": "ncit:C66944",
              "code": "C66944",
              "name": "Brentuximab Vedotin",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C66944"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:1147320",
                  "code": "1147320",
                  "name": "brentuximab vedotin",
                  "system": "RxNorm",
                  "systemVersion": "20250602",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1147320"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:37017170",
                  "code": "37017170",
                  "name": "Brentuximab vedotin",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/37017170"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:713395006",
                  "code": "713395006",
                  "name": "Brentuximab vedotin",
                  "system": "SNOMED",
                  "systemVersion": "2025-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=713395006&edition=MAIN/2025-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:40241969",
                  "code": "40241969",
                  "name": "brentuximab vedotin",
                  "system": "OMOP",
                  "systemVersion": "v20250827",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/40241969"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "target CD30 antigens"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Targeted therapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          }
        ]
      }
    }
  ]
}